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ABSTRACT
Zona pellucida glycoprotein 3 (ZP3) has been ascribed as a
putative primary sperm receptor during fertilization in humans.
Herein, attempts have been made to delineate the functional
domain of human ZP3. ZP3 has been cloned and expressed in a
baculovirus expression system as N-terminal fragments (amino
acid [aa] residues 1–175 [pAc-ZP3(1–175 aa)] and 23–175 [pBg-
ZP3(23–175 aa)]) and as C-terminal fragments (aa residues 214–305
[pBg-ZP3(214–305 aa)] and 214–348 [pBg-ZP3(214–348 aa)]). ZP3
encompassing both N- and C-terminal fragments corresponding
to aa residues 1–370 (pAc-ZP3[1–370 aa]) has also been expressed.
Lectin-binding analysis with these recombinant proteins revealed
the presence of N- and O-linked glycosylation. Significant
induction of acrosomal exocytosis was observed when capaci-
tated sperm were incubated with pBg-ZP3(214–348 aa), pBg-
ZP3(214–305 aa), and pAc-ZP3(1–370 aa) (P , 0.05), whereas
incubation with pAc-ZP3(1–175 aa) and pBg-ZP3(23–175 aa) failed
to do so under similar experimental conditions. However, N- and
C-terminal fragments labeled with fluorescein isothiocyanate
revealed binding to the anterior head of capacitated human
spermatozoa. Escherichia coli-expressed ZP3 C-terminal frag-
ments and chemically deglycosylated pBg-ZP3(214–348 aa) failed to
induce a significant (P . 0.05) increase in acrosomal exocytosis,
suggesting the relevance of glycosylation in imparting functional
activity to ZP3 C-terminal fragments. pBg-ZP3(214–348 aa)-medi-
ated induction of acrosomal exocytosis is regulated by Gi protein,
extracellular calcium, GABA(A) [gamma aminobutyric acid (A)]
receptor-mediated Cl channel, and T-type voltage-operated
calcium channels. Taken together, the results of these studies
suggest that the functional activity of human ZP3 resides in its C-
terminal domain.
acrosome reaction, baculovirus expression system, recombinant
human ZP3 fragments, sperm, zona pellucida domain
INTRODUCTION
The mammalian oocyte is surrounded by an acellular
glycoproteinaceous matrix termed the zona pellucida (ZP). It
has a pivotal role in species-specific sperm-egg recognition and
binding, induction of acrosomal exocytosis in the ZP-bound
spermatozoa, avoidance of polyspermy, and protection of the
embryo before implantation [1]. In contrast to mouse ZP,
human ZP matrix is composed of four glycoproteins designated
as ZP1, ZP2, ZP3, and ZP4, with ZP4 being a pseudogene in
mouse [2–4]. In mice and humans, ZP3 is a putative primary
sperm receptor, as it has a critical role in initial binding of the
spermatozoa to the oocyte and in induction of acrosomal
exocytosis [5–10].
Human ZP3 is a 424-amino acid (aa)-long polypeptide
encoded by eight exons. It has a 22-aa-long N-terminal
hydrophobic signal peptide sequence that drives the protein
into the secretory pathway [11]. A tetrabasic consensus furin
cleavage site, RNRR (349–352 aa), is present upstream of a
hydrophobic transmembrane-like domain (TMD [387–
409 aa]). TMD anchors the glycoproteins in secretory vesicles
and plasma membrane [12]. ZP3 is heterogeneously glycosy-
lated with complex-type asparagine-linked (N-linked) and
serine(Ser)/threonine-linked (O-linked) oligosaccharides [13].
Mass spectrometric analysis of recombinant human ZP3 has
revealed three (Asn125, Asn147, and Asn272) of four potential N-
linked glycosylation sites and two clusters (156–173 aa and
260–281 aa) of potential O-linked glycosylation sites [14].
Mature human ZP3 has 12 cysteine (Cys) residues. Of these,
eight are conserved across species in ZP3 polypeptide, forming
four disulfide bonds. The first four Cys residues (Cys46/Cys140
and Cys78/Cys99) form a loop-within-loop motif (1 to 4 and 2
to 3), and the second four (Cys217/Cys282 and Cys239/Cys300)
participate in the formation of a crossover motif (1 to 3 and 2 to
4). The remaining four Cys residues (Cys319, Cys321, Cys322,
and Cys327) lying within a tight cluster toward the C-terminus
are linked by two unassigned disulfide linkages, which could
not be determined because of the absence of any proteolytic
cleavage site [14]. In addition, ZP3 has a homologous region,
spanning 45–304 aa, known as the ZP domain, which is
conserved in other zona proteins across species, along with a
variety of other extracellular proteins of diverse functions such
as uromodulin (UMOD or Tamm-Horsefall protein), trans-
forming growth factor, beta receptor III, and tectorin alpha and
beta [15]. The ZP domain in human ZP3 consists of two
conserved subdomains, an N-terminus that is followed by an
internal hydrophobic patch (IHP [167–173 aa]) and a C-
terminus that is followed by an external hydrophobic patch
(EHP [362–368 aa]) separated by a short protease-sensitive
hinge. In mice, IHP and EHP are essential for incorporation of
ZP3 into the ZP matrix [12]. The N-terminal subdomain of the
ZP domain is involved in polymerization of murine ZP3 [16].
The functional importance of different domains of human ZP3,
based on disulfide linkages of conserved Cys residues, needs
more elaboration.
In this study, human ZP3 polypeptide was cloned and
expressed in baculovirus as the following fragments: 1) ZP3
corresponding to aa residues 1–175, including signal peptide
and IHP (pAc-ZP3[1–175 aa]); 2) aa residues 23–175, excluding
signal peptide but including IHP (pBg-ZP3[23–175 aa]) from the
N-terminal region; 3) ZP3 corresponding to aa residues 214–
305 spanning the C-terminus of the ZP domain (pBg-
ZP3[214–305 aa]); and 4) aa residues 214–348, which include
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the C-terminus of ZP3 up to the consensus furin cleavage site
(pBg-ZP3[214–348 aa]). ZP3 corresponding to aa residues 1–370
(pAc-ZP3[1–370 aa]), encompassing both domains was used as a
positive control in the baculovirus expression system. Both
ZP3 C-terminal fragments were also expressed in Escherichia
coli to obtain these in nonglycosylated forms. These recom-
binant ZP3 fragments were investigated for induction of
acrosomal exocytosis in capacitated human sperm, as well as
their binding characteristics. Furthermore, using various
pharmacological inhibitors, the downstream signaling events
associated with acrosomal exocytosis mediated by ZP3
fragments were delineated.
MATERIALS AND METHODS
Cloning and Expression of cDNA Encoding Human ZP3
Fragments in Baculovirus and E. coli
The cDNAs encoding human ZP3 corresponding to aa residues 1–175 and
1–370 were cloned in baculovirus transfer vector pAcHLT-A (PharMingen,
San Diego, CA) downstream of the polyhistidine tag and under the control
of late polyhedrin promoter by following standard procedures as described
previously [8] and were designated as pAc-ZP3(1–175 aa) and pAc-
ZP3(1–370 aa), respectively. ZP3 N- and C-terminal fragments encompassing
23–175 aa (pBg-ZP3[23–175 aa]), 214–348 aa (pBg-ZP3[214–348 aa]), and 214–
305 aa (pBg-ZP3[214–305 aa]) were cloned in baculovirus transfer vector
pBacGus-6 (Novagen, Madison, WI) with gp64 signal peptide sequence
downstream of a modified gp64 tandem promoter and a polyhistidine tag at
the N-terminus according to the manufacturer’s instructions. The purified
recombinant baculovirus transfer vectors were used to cotransfect Spodoptera
frugiperda (Sf21) insect cells grown in Grace Insect Cell Culture Medium
(Invitrogen Corp., Carlsbad, CA) supplemented with 0.33% Lactalbumin
Hydrolysate (Invitrogen Corp.), Yeastolate Ultrafiltrate (Invitrogen Corp.),
and 10% fetal calf serum using the BD Baculogold transfection kit
(PharMingen) or the BacVector-2000 DNA kit (Novagen), facilitating in
vivo recombination of the zona insert into the AcNPV genome. To produce a
recombinant clone, Sf21 cells were infected with increasing dilutions of
transfection supernatant for 1 h, overlaid with 1.5% AgarPlaque Plus agarose
(PharMingen), and incubated at 278C for 96 h. Plaques were visualized by
staining with 0.03% neutral red solution, picked up, and used to infect Sf21
cells. After 96 h of incubation, the cell lysate and supernatant were checked
for the presence of the recombinant protein by Western blot analysis as
described previously [8]. For large-scale production of the recombinant
proteins, a suspension culture of 50 3 106 Sf 21 insect cells growing in a
spinner bottle (Thermolyne; Barnstead International, Dubuque, IA) was
incubated with the respective recombinant virus at a multiplicity of infection
of three at 42 rotations/min on a biological stirrer (Thermolyne) at 278C for
96 h, after which the cells were pelleted at 1000 3 g for 15 min, and
recombinant proteins were purified from cell pellet or from culture
supernatants using Ni-NTA resin essentially as described previously [8].
Protein concentration was determined using bicinchoninic acid assay (Pierce,
Rockford, IL) using bovine serum albumin (BSA) (Sigma-Aldrich Inc., St.
Louis, MO) as the standard.
In addition, cDNAs encoding human ZP3 corresponding to aa residues
214–348 (ZP3[214348 aa]) and 214–305 (ZP3[214305 aa]) were cloned down-
stream of the T7 promoter in pRSET-A vector (Invitrogen Corp.) in frame with
a polyhistidine tag at its N-terminus. For expression, these constructs were used
to transform the BL21[DE3] pLysS strain of E. coli (Stratagene, La Jolla, CA)
deficient in ompT and lon proteases, and one of the positive clones was used for
expression of the respective recombinant protein. Recombinant proteins were
expressed at the shake flask level in the presence of 1 mM isopropyl-b-D-
thiogalactopyranoside after the cell density reached an absorbance of
approximately 0.6 at 600 nm (A600) for induction of expression of the protein
for 2.5 h. The recombinant proteins were purified using Ni-NTA affinity
chromatography under denaturing conditions and were renatured by extensive
dialysis in the presence of oxidized/reduced glutathione essentially as described
previously [8].
Characterization of Recombinant Human ZP3 Fragments
SDS-PAGE and Western blot. To characterize the E. coli- and baculovirus-
expressed recombinant ZP3 fragments, the respective cell pellets, culture
supernatants, or purified proteins were boiled for 10 min in 23 SDS-PAGE
sample buffer (62.5 mM Tris [pH 6.8], 2% SDS, 10% glycerol, 5% b-
mercaptoethanol, and 0.001% bromophenol blue) and were resolved on a 0.1%
SDS-10% polyacrylamide gel essentially as described previously [8]. The
proteins were stained using Coomassie brilliant blue or were processed for
Western blot as described previously using rabbit polyclonal antibodies against
recombinant human pAc-ZP3(1–424 aa) [9].
Lectin-binding analysis. To characterize the nature of glycosylation,
microtitration plates (Nunclon, Roskilde, Denmark) were coated with purified
baculovirus-expressed pAc-ZP3(1–175 aa), pAc-ZP3(1–370 aa), pBg-ZP3(23–175 aa),
pBg-ZP3(214–348 aa), and pBg-ZP3(214–305 aa) at a concentration of 500 ng/well
in 50 mM PBS (pH 7.4) for 1 h at 378C, followed by overnight incubation at
48C. Using similar experimental conditions, microtitration plates were coated
with E. coli-expressed ZP3(214–305 aa) and ZP3(214–348 aa). All subsequent
washings were performed three times in 50 mM PBS with 0.1% Tween-20
(PBST). The plates were blocked with PBST (200 ll/well) for 1.5 h at 378C,
followed by incubation with various biotinylated lectins (100 ng/well; Vector
Laboratories, Burlingame, CA) at 378C for 1 h. The bound lectins were
revealed by incubation with horseradish peroxidase-conjugated streptavidin
(1:3000, 100 ll/well; Pierce) at 378C for 1 h. Plates were subsequently
processed by determination of enzyme activity as described previously [8]. The
specificity of reactivity of lectins with baculovirus-expressed ZP3 fragments
was further confirmed by lectin blot [8].
Chemical deglycosylation of pBg-ZP3(214–348 aa). Baculovirus-expressed
recombinant pBg-ZP3(214–348 aa) was chemically deglycosylated using trifluor-
omethanesulphonic acid (TFMS) (Sigma-Aldrich Inc.) as described previously
[17]. In brief, recombinant protein (250 lg) was dialyzed extensively against
distilled water to remove Tris, followed by lyophilization in a reaction vial
(Borosil Glass Works Ltd., Mumbai, India). The lyophilized protein was further
dried overnight under vacuum. To the dried protein, 15 ll of anhydrous TFMS
and 5 ll of anisole (Sigma-Aldrich Inc.) were added, and the reaction mixture
was incubated at 08C for 2 h under nitrogen with intermittent mixing. After
incubation, the contents of the reaction vial were transferred to a microfuge
tube, and 1.5 ml of a 9:1 mixture of precooled (208C) ether:pyridine was
added dropwise, followed by centrifugation at 10 0003 g for 5 min. The pellet
was resuspended in 150 ll of 0.1 M ammonium bicarbonate (pH 7.4) and
dialyzed using the Tube-O-DIALYZER (G-Biosciences, St. Louis, MO)
extensively against the same buffer, followed by two changes with 20 mM Tris
(pH 7.4).
Induction of the Acrosome Reaction
by Recombinant Human ZP3 Fragments in Capacitated
Human Spermatozoa
All experiments using human spermatozoa were performed with informed
consent and after clearance from the institutional biosafety and human ethical
committee. Semen samples were collected from healthy donors after 3 days of
sexual abstinence and were subjected to liquefaction at room temperature for
30 min. The motile sperm were isolated by two-step Percoll density gradient
as described previously [18]. The sperm (10 3 106 cells/ml) were capacitated
in Biggers-Whitten-Whittingham (BWW) medium [19] supplemented with
2.6% BSA for 16 h at 378C with 5% CO2 in humidified air in aliquots of 500
ll. Capacitated sperm (1 3 106 in BWW plus 0.3% BSA) were incubated at
378C with 5% CO2 in humidified air for varying times and in the presence of
various concentrations of different recombinant ZP3 fragments in a total
reaction volume of 100 ll. To account for spontaneous induction of the
acrosome reaction, sperm were also incubated with BWW plus 0.3% BSA
alone. Calcium ionophore (10 lM, A23187; Sigma-Aldrich Inc.) served as a
positive control in all experiments. After incubation, the sperm were washed
with 50 mM PBS (pH 7.4) and fixed in chilled methanol for 30 sec, and 20-ll
aliquots were spotted on poly-L-lysine-coated slides (Sigma-Aldrich Inc.) in
duplicates. The spots were air dried and stained with 5 lg/ml of
trimethylrhodamine isothiocyanate-conjugated Pisum sativum agglutinin
(TRITC-PSA; Vector Laboratories) for 30 min at room temperature. Any
spermatozoa that demonstrated complete loss of TRITC-PSA staining in the
acrosome or that revealed staining at the equatorial region were classified as
acrosome reacted. Sperm showing TRITC fluorescence in the acrosomal
region of the head were classified as acrosome intact. All slides were read
‘‘blind’’ with coded samples under an Eclipse 80i epifluorescence microscope
(Nikon, Chiyoda-ku, Tokyo, Japan) using an oil immersion objective. Two
hundred sperm were scored for every spot, and the percentage of the acrosome
reaction was calculated by dividing the number of acrosome-reacted sperm by
the total number of sperm counted and multiplying by 100. Each experiment
was repeated at least five times by collecting semen samples from at least
three individual donors.
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Delineation of Downstream Signaling Events Associated
with ZP3 Fragment-Mediated Induction
of Acrosomal Exocytosis
To understand the mechanism of action of functionally active recombinant
human ZP3 fragments, the acrosome reaction was induced in presence of
different pharmacological inhibitors. Capacitated spermatozoa were pretreated
for 10 min at 378C with 5% CO2 in humidified air before addition of the
recombinant protein: pimozide (10 lM; Sigma-Aldrich Inc.) T-type Ca2þ
channel blocker (CCB), picrotoxin (100 lM; Sigma-Aldrich Inc.) GABA(A)
[gamma aminobutyric acid (A)] receptor antagonist, ethyleneglycoltetracetic
acid (EGTA) (8 mM; Sigma-Aldrich Inc.) extracellular calcium chelator, and
verapamil (10 lM; Sigma-Aldrich Inc.) and diltiazem (10 lM; Sigma-Aldrich
Inc.) L-type CCBs. In addition, pretreatment with pertussis toxin (PTX) (0.1 lg/
ml; Sigma-Aldrich Inc.), an inhibitor of Gi protein, was performed for 30 min.
Evaluation of the Binding of Recombinant ZP3 Fragments
to Human Spermatozoa
Recombinant ZP3 fragments were conjugated with fluorescein isothio-
cyanate (FITC), and the fluorescein:recombinant protein molar ratio was
determined as described previously [9]. The FITC-labeled recombinant proteins
were used for studying their binding characteristics with capacitated and
acrosome-reacted human spermatozoa as described previously [9]. The ability
of recombinant pBg-ZP3(23–175 aa) and pBg-ZP3(214–348 aa) to compete with
FITC-labeled pAc-ZP3(1–370 aa) for binding to capacitated human spermatozoa
was also evaluated by competitive inhibition studies. Essentially, capacitated
sperm (5 3 106) were incubated with 10 pmol of FITC-labeled pAc-
ZP3(1–370 aa) alone or in the presence of 100 pmol of cold pAc-ZP3(1–370 aa),
pBg-ZP3(23–175 aa), or pBg-ZP3(214–348 aa) in a reaction volume of 50 ll at 378C
and 5% CO2 in humidified air for 15 min, followed by 30 min at 48C.
After incubation, sperm were processed for binding of FITC-labeled pAc-
ZP3(1–370 aa) as described previously [9].
Statistical Analysis
The results pertaining to binding of recombinant human ZP3 fragments to
the capacitated/acrosome-reacted spermatozoa and to induction of the acrosome
reaction are presented as the mean 6 SEM of a minimum three independent
experiments using semen samples from at least two different donors. Statistical
analysis was performed by comparing the means of the control medium (BWW
plus 0.3% BSA) and experimental sets or within two experimental groups by
FIG. 1. Analysis of baculovirus-expressed
human ZP3 fragments by Western blot. Sf21
(1 3 106/well) cells were transfected with
wild-type AcNPV or recombinant virus and
were incubated at 278C for 96 h. The cell
pellet lysate and supernatant were resolved
by 0.1% SDS-10% PAGE, followed by
Western blot using rabbit polyclonal anti-
bodies raised against recombinant pAc-
ZP3(1–424 aa) as described in Materials and
Methods. Panels A, B, C, D, and E depict the
expression of pAc-ZP3(1–175 aa), pAc-ZP3(1–
370 aa), pBg-ZP3(23–175 aa), pBg-ZP3(214–348
aa), and pBg-ZP3(214–305 aa), respectively.
Lanes 1 and 2: wild-type AcNPV and
recombinant virus-infected cell pellet ly-
sate, respectively; Lanes 3 and 4: wild-type
AcNPV and recombinant virus-infected cell
supernatant, respectively. M, molecular
weight markers.
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using one-way ANOVA, followed by Newman-Keuls multiple comparisons
test. P , 0.05 was considered statistically significant.
RESULTS
Characteristics of Recombinant Human ZP3 Fragments
The recombinant human pAc-ZP3(1–175 aa) and pAc-ZP3(1–370 aa)
(cloned in pAcHLT-A transfer vector) and pBg-ZP3(23–175 aa),
pBg-ZP3(214–348 aa), and pBg-ZP3(214–305 aa) (cloned in pBac-
Gus-6 transfer vector) were expressed as polyhistidine-tagged
fusion proteins using the baculovirus expression system.
Western blot analysis using rabbit polyclonal antibodies
generated against baculovirus-expressed recombinant pAc-
ZP3(1–424 aa) [9] revealed that pAc-ZP3(1–175 aa) and pAc-
ZP3(1–370 aa) were expressed in cell pellet only (Fig. 1, A and
B; lane 2) and were absent in culture supernatant (Fig. 1,
A and B; lane 4). However, pBg-ZP3(23–175 aa), pBg-
ZP3(214–348 aa), and pBg-ZP3(214–305 aa) were expressed in
cell lysate and were secreted in the culture supernatant by
insect cells infected with respective recombinant virus (Fig. 1,
C–E; lanes 2 and 4). Polyclonal antibodies against pAc-
ZP3(1–424 aa) failed to show any reactivity with cell lysate or
culture supernatant of Sf21 cells infected with wild-type
AcNPV (Fig. 1, A–E; lanes 1 and 3). Expressed recombinant
pAc-ZP3(1–175 aa) and pAc-ZP3(1–370 aa) were purified from
cell pellet and pBg-ZP3(23–175 aa), pBg-ZP3(214–348 aa), and
pBg-ZP3(214–305 aa) from culture supernatant using Ni-NTA
affinity chromatography. SDS-PAGE and Western blot
analysis of the purified pAc-ZP3(1–175 aa) revealed a dominant
band corresponding to ;35 kDa, with two minor bands of
higher molecular weight (Fig. 2, A and B). The purified pAc-
ZP3(1–370 aa) resolved as a doublet corresponding to ;56–58
kDa (Fig. 2, C and D). Analysis of the purified pBg-
ZP3(23–175 aa) (Fig. 2, E and F) revealed two bands in the
range of ;25–29 kDa, and analysis of the purified pBg-
ZP3(214–348 aa) (Fig. 2, G and H) revealed two bands in the
range of 21–25 kDa. The purified pBg-ZP3(214–305 aa) (Fig. 2,
I and J) resolved as a broad band corresponding to ;21 kDa.
FIG. 2. Analysis of purified recombinant
human ZP3 proteins expressed in the
baculovirus expression system by SDS-
PAGE and Western blot. The Ni-NTA
affinity-purified baculovirus-expressed re-
combinant human ZP3 proteins were re-
solved by 0.1% SDS-10% PAGE under
reducing conditions. Lane 1 in B, D, F, H,
and J shows the SDS-PAGE profile (5 lg of
recombinant protein per lane) and in A, C,
E, G, and I shows the Western blot profile (1
lg of recombinant protein per lane) of
purified recombinant pAc-ZP3(1–175 aa),
pAc-ZP3(1–370 aa), pBg-ZP3(23–175 aa), pBg-
ZP3(214–348 aa), and pBg-ZP3(214–305 aa),
respectively. M, molecular weight markers.
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ZP3 C-terminal fragments ZP3(214–348 aa) and ZP3(214–305 aa)
were expressed as polyhistidine-tagged fusion proteins in E.
coli. The SDS-PAGE and Western blot analysis of the
purified E. coli-expressed ZP3(214–305 aa) and ZP3(214–348 aa)
revealed dominant bands of ;21 kDa and ;24 kDa,
respectively (Supplemental Fig. S1 available at www.
biolreprod.org).
Baculovirus-Expressed Recombinant Human ZP3
Fragments Have Both N- and O-Linked Glycosylation
To determine the nature of glycosylation, purified
recombinant proteins were analyzed for binding characteris-
tics with various lectins in an ELISA (Table 1). Baculovirus-
expressed recombinant ZP3 fragments pAc-ZP3(1–175 aa),
pAc-ZP3(1–370 aa), pBg-ZP3(23–175 aa), pBg-ZP3(214–348 aa),
and pBg-ZP3(214–305 aa) showed reactivity with concanavalin
A (Con A [mannose a 1–3/ mannose a 1–6]), jacalin (a-O-
glycosides of Gal or GalNAc moieties), and PSA (a-linked
mannose). Under similar conditions, E. coli-expressed
ZP3(214–305 aa) and ZP3(214–348 aa) did not reveal any reactivity
with these lectins, suggesting that these are not glycosylated.
The presence of both O- and N-linked glycosylation on
baculovirus-expressed recombinant ZP3 fragments was con-
TABLE 1. Lectin binding characteristics with various recombinant ZP3
fragments in ELISA.
Recombinant
protein
Absorbance at 490 nm with lectinsa,b
ConA Jacalin PSA
pAc-ZP3(1–175 aa) 2.73 1.40 0.33
pAc-ZP3(1–370 aa) 2.91 2.48 0.59
pBg-ZP3(23–175 aa) 2.81 2.67 1.99
pBg-ZP3(214–348 aa) 2.82 2.97 1.09
pBg-ZP3(214–305 aa) 2.72 2.68 1.32
E. coli ZP3(214–305 aa) 0.18 0.07 0.14
E. coli ZP3(214–348 aa) 0.20 0.04 0.11
a Values are expressed as absorbance obtained with various lectins
binding to the respective recombinant protein, after deducting the
nonspecific binding of the lectins to the uncoated wells.
b Each value represents a mean of duplicate experiments.
TABLE 2. Induction of acrosomal exocytosis in capacitated human
sperm by recombinant human ZP3 fragments.
Treatmenta
Percentage induction of
acrosomal exocytosis
(mean 6 SEM)b
Statistical
significance
Group I
Control (BWW þ 0.3% BSA) 15.1 6 0.9
Fetuin 16.9 6 0.3 P ¼ 0.4900c
Human pAc-ZP2(1–745 aa) 18.2 6 0.6 P ¼ 0.1842c
Calcium Ionophore (10 lM) 52.2 6 2.9 P ¼ 0.0024c*
Group II
pAc-ZP3(1–175 aa) 18.4 6 2.1 P ¼ 0.1711c
pBg-ZP3(23–175 aa) 18.0 6 0.9 P ¼ 0.2217c
pBg-ZP3(214–348 aa) 48.9 6 2.7 P ¼ 0.0013c*
pBg-ZP3(214–305 aa) 32.4 6 2.3 P ¼ 0.0069c*
pAc-ZP3(1–370 aa) 45.3 6 2.2 P ¼ 0.0013c*
Group III
E. coli-expressed ZP3(214–348 aa) 18.5 6 0.5 P ¼ 0.2737c
E. coli-expressed ZP3(214–305 aa) 16.7 6 1.4 P ¼ 0.6045c
Group IV
Control (BWW þ 0.3% BSA) 12.8 6 1.2
Untreated pBg-ZP3(214–348 aa) 48.0 6 2.2
TFMS-deglycosylated
pBg-ZP3(214–348 aa) 19.4 6 0.5 P ¼ 0.0048d*
a Capacitated sperm were incubated with the recombinant proteins at a
concentration of 10 pmol/100 ll for 60 min.
b Percentage induction of acrosomal exocytosis was calculated by
dividing the number of acrosome reacted sperm by total number of
sperm counted and multiplying by 100; values represent mean 6 SEM of
at least three independent experiments.
c Statistical significance with respect to the medium control was
calculated by one-way ANOVA followed by Newman-Keuls multiple
comparison test.
d Statistical significance with respect to untreated pBg-ZP3(214–348 aa) was
calculated by paired t-test.
* Values are statistically significant.
FIG. 3. Dose-response and time kinetics studies of pBg-ZP3(214–348 aa)-
mediated induction of acrosomal exocytosis in capacitated human
spermatozoa. A) Capacitated human sperm (1 3 106/100 ll) were
incubated with recombinant pBg(214–348 aa) at varying concentrations for
60 min and were analyzed for acrosomal status by TRITC-PSA staining as
described in Materials and Methods. Bar with dotted line represents
medium control. B) To study the optimum time required for induction of
acrosomal exocytosis, capacitated sperm (13 106/100 ll) were incubated
with 10 pmol of pBg(214–348 aa) per reaction for varying times. Bar with
dotted line represents analysis of acrosome reaction immediately after
adding the recombinant protein. The y-axis in A and B represents
percentage induction of acrosomal exocytosis calculated by dividing the
number of acrosome-reacted sperm by the total number of sperm counted
and multiplying by 100. Values are the mean 6 SEM of five different
experiments using semen samples from at least three different donors.
*Values are statistically significant when compared with respective
controls.
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firmed by lectin blots using Con A (N-linked glycosylation)
and jacalin (O-linked glycosylation) (Supplemental Fig. S2).
Baculovirus-Expressed C-Terminal ZP3 Fragment Induces
Acrosomal Exocytosis in Capacitated Human Sperm
The E. coli- and baculovirus-expressed ZP3 fragments were
evaluated for their ability to induce acrosomal exocytosis in the
capacitated human spermatozoa. Treatment of capacitated
sperm with various recombinant human ZP3 fragments did
not result in any significant decrease in the viability of the
sperm as determined by one-step eosin-nigrosin staining
method [20]. Incubation of the capacitated sperm with
baculovirus-expressed pAc-ZP3(1–175 aa), pBg-ZP3(23–175 aa),
and E. coli-expressed ZP3(214–305 aa) and ZP3(214–348 aa) did
not induce a significant increase (P . 0.05) in acrosomal
exocytosis compared with the control medium (15.5% 6
0.6%) (Table 2). However, when capacitated sperm were
incubated with pBg-ZP3(214–348 aa) and pBg-ZP3(214–305 aa), a
significant increase (50.5% 6 1.3% and 32.4% 6 2.3%,
respectively) in induction of acrosomal exocytosis was
observed (P ¼ 0.0013 and P ¼ 0.0069, respectively). The
extent of induction of acrosomal exocytosis mediated by
recombinant pBg-ZP3(214–348 aa) was similar to that of
recombinant pAc-ZP3(1–370 aa), which incorporates both N-
and C-terminal domains. Chemical deglycosylation of pBg-
ZP3(214–348 aa) resulted in a significant decrease (P¼ 0.0048) in
its ability to induce the acrosome reaction compared with
untreated recombinant protein. Calcium ionophore (A23187), a
chemical agonist of acrosomal exocytosis used as a positive
control, also showed a significant increase in the percentage of
sperm undergoing the acrosome reaction (51.6% 6 0.7%).
Fetuin and pAc-ZP2(1–745 aa) generated as described earlier [8]
and used as internal controls failed to induce any significant
increase in acrosomal exocytosis compared with control
medium. Dose-response studies with pBg-ZP3(214–348 aa)
revealed that a dose as low as 2.5 pmol/reaction induced a
significant increase in acrosomal exocytosis in capacitated
sperm (Fig. 3A). No further increase in acrosomal exocytosis
was observed if the concentration of ZP3 was increased beyond
40 pmol/reaction. A time kinetics study revealed that
significant induction of acrosomal exocytosis by pBg-
ZP3(214–348 aa) can be seen as early as 5 min after exposure
of capacitated spermatozoa to recombinant protein and that
acrosomal exocytosis plateaus at 60 min (Fig. 3B).
Delineation of Downstream Signaling Events Associated
with Recombinant pBg-ZP3(214–348 aa)-Mediated Induction
of Acrosomal Exocytosis
Induction of acrosomal exocytosis mediated by recombinant
pBg-ZP3(214–348 aa) required extracellular Ca
2þ, as prior
incubation of capacitated sperm in BWW medium with EGTA
(8 mM) before exposure to recombinant protein led to a
significant decrease in acrosomal exocytosis (Table 3).
Acrosomal exocytosis mediated by pBg-ZP3(214–348 aa) was
inhibited by prior incubation of capacitated sperm with the T-
type CCB pimozide (10 lM), whereas the L-type CCBs
verapamil (10 lM) and diltiazem (10 lM) failed to do so. The
GABA(A) receptor antagonist picrotoxin (100 lM) also
inhibited induction of acrosomal exocytosis mediated by
pBg-ZP3(214–348 aa). Induction of acrosomal exocytosis by
recombinant pBg-ZP3(214–348 aa) is also dependent on activa-
tion of the Gi pathway, as pretreatment with PTX (0.1 lg/ml)
led to a significant decrease in induction of the acrosome
reaction (52.6% 6 0.7% to 21.4% 6 0.5%, P , 0.01).
FIG. 4. Representative binding profile of
baculovirus-expressed human ZP3 frag-
ments with human spermatozoa. Capaci-
tated sperm (5 3 106/50 ll) were incubated
with FITC-conjugated baculovirus-ex-
pressed recombinant pBg-ZP3(23–175 aa) and
pBg-ZP3(214–348 aa) and were processed as
described in Materials and Methods. The
acrosomal status was determined by label-
ing the sperm with TRITC-PSA. A and B)
Binding profile of pBg-ZP3(23–175 aa) with
capacitated sperm. C and D) Binding profile
of pBg-ZP3(214–348 aa) with capacitated
spermatozoa. The images were captured
using a Nikon Eclipse 80i epifluorescence
microscope. The following is shown in each
panel: PSA-TRITC fluorescence (a), FITC-
ZP3 protein fluorescence (b), overlap of the
fluorescent frames (c), and phase contrast
(d).
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Binding Characteristics of Recombinant Human ZP3
Fragments to Spermatozoa
The fluorescein:recombinant protein molar ratios of the
FITC-labeled recombinant proteins were as follows: 1.2 for
E. coli-expressed ZP3(214–305 aa); 1.8, 1.3, and 1.0 for pAc-
ZP3(1–370 aa), pBg-ZP3(23–175 aa), and pBg-ZP3(214–348 aa); and
1.8 for fetuin. These FITC-labeled recombinant human ZP3
fragments were analyzed for their ability to bind to human
spermatozoa using a direct binding assay. The acrosomal status
of the spermatozoa showing binding of the recombinant
proteins was simultaneously assessed using TRITC-PSA.
Binding studies revealed that all four recombinant ZP3
fragments bind to the anterior head or equatorial segment of
the capacitated spermatozoa. In acrosome-reacted sperm, no
binding of the recombinant proteins was observed to the
anterior head of the spermatozoa, whereas binding to the
equatorial segment was observed. A representative binding
profile of pBg-ZP3(23–175 aa) and pBg-ZP3(214–348 aa) with
capacitated human spermatozoa is shown in Figure 4. Under
similar experimental conditions, FITC-labeled fetuin did not
show any binding to the capacitated or acrosome-reacted
spermatozoa. Computation of the binding characteristics for
each recombinant ZP3 fragment revealed that 14.9% 6 4.1%,
21.9% 6 3.2%, and 24.3% 6 2.1% of capacitated sperm
exhibited binding of baculovirus-expressed pBg-ZP3(23–175 aa),
pBg-ZP3(214–348 aa), and pAc-ZP3(1–370 aa), respectively. Also,
15.2% 6 2.7% of capacitated sperm showed binding with
E. coli-expressed ZP3(214–305 aa) vs. 2.7% 6 0.7% with fetuin.
The binding patterns for each ZP3 protein are shown in
Supplemental Table S1. Binding of FITC-labeled pAc-
ZP3(1–370 aa) (10 pmol) with capacitated spermatozoa was
investigated in the presence of a 1:10 molar excess of cold
pAc-ZP3(1–370 aa), pBg-ZP3(23–175 aa), and pBg-ZP3(214–348 aa).
A reduction of 67.9% 6 2.2% in the binding of FITC-labeled
pAc-ZP3(1–370 aa) was observed in the presence of cold pAc-
ZP3(1–37 aa), whereas cold pBg-ZP3(23–175 aa) and pBg-
ZP3(214–348 aa) resulted in 49.2% 6 2.9% and 66.3% 6 4.1%
reductions, respectively.
DISCUSSION
Human ZP3 and other human zona proteins share a
sequence motif referred to as the ZP domain comprising
;260 aa with conserved polar and hydrophobic patterns [15].
The ZP domain of human ZP3 has eight conserved Cys
residues, whereas the ZP domains of ZP1, ZP2, and ZP4 have
10 Cys residues each [21]. The first four conserved Cys
residues of the ZP domain are engaged in identical intramo-
lecular disulfide bonds in all ZP proteins, but the presence of
two extra Cys residues within the C-terminal portion of the ZP
domains of ZP1, ZP2, and ZP4 renders disulfide bonds of
conserved Cys 5–8 different from those of ZP3. This disulfide
linkage pattern of the ZP domain suggests that it is a bipartite
structure with two independently folding subdomains [15].
Following murine investigations and the elucidation of
disulfide linkages and N- and O-linked glycosylation sites in
human ZP3 using Liquid Chromatography Quadrupole time-
of-flight (LC-QTOF) tandem mass spectrometry [14], we
herein attempted to delineate the functional domain of human
ZP3 using N- and C- terminal fragments. To assess the
importance of signal peptide for proper glycosylation of the
ZP3 polypeptide, native (heterologous for insect cell host
machinery) and gp64 secretory signal peptide-harboring
constructs were expressed in Sf21 insect cells using a
baculovirus expression system. To delineate the importance
of Cys319, Cys321, Cys322, and Cys327 residues, the ZP3 C-
terminus was further truncated to the end of the ZP domain
(214–305 aa).
Expression of human ZP3 fragments as polyhistidine-tagged
fusion proteins allowed their purification by Ni-NTA affinity
column. Minor differences in the apparent molecular weights of
purified recombinant ZP3 fragments in SDS-PAGE vs. Western
blot may have been observed because prestained markers were
used in Western blot, whereas unstained markers were used in
SDS-PAGE. A higher increase in apparent molecular weight in
the case of pAc-ZP3(1–175 aa) and pBg-ZP3(23–175 aa) compared
with pBg-ZP3(214–348 aa) may be because there are two N-linked
glycosylation sites in the N-terminal fragment of human ZP3
TABLE 3. Induction of acrosome reaction in capacitated human sperm by recombinant human pBg-ZP3(214–348 aa) in presence or absence of various
pharmacological inhibitors.
Treatmenta Percentage induction of acrosomal exocytosis (mean 6 SEM)b Statistical significance
Group I
Control (BWW þ 0.3% BSA) 15.5 6 1.6
pBg-ZP3(214–348 aa) 50.0 6 1.6 P ¼ 0.0002*c
pBg-ZP3(214–348 aa) þ ethanol 49.9 6 1.1 P ¼ 0.0001*c, P ¼ 0.9369d
pBg-ZP3(214–348 aa) þ PTX (0.1 lg/ml) 17.9 6 0.8 P ¼ 0.2597c, P ¼ 0.0001*d
pBg-ZP3(214–348 aa) þ EGTA (8 mM) 26.5 6 1.1 P ¼ 0.0045*c, P ¼ 0.0004*d
pBg-ZP3(214–348 aa) þ picrotoxin (10 lM) 20.3 6 1.8 P ¼ 0.1182c, P ¼ 0.0003*d
Group II
pBg-ZP3(214–348 aa) þ water 49.9 6 0.5 P ¼ 0.0001*c, P ¼ 0.9006d
pBg-ZP3(214–348 aa) þ DMSO 48.6 6 0.4 P ¼ 0.0001*c, P ¼ 0.4658d
pBg-ZP3(214–348 aa) þ pimozide (10 lM) 20.9 6 1.5 P ¼ 0.2597c, P ¼ 0.0001*d
pBg-ZP3(214–348 aa) þ amiloride (10 lM) 28.2 6 2.1 P ¼ 0.0078*c, P ¼ 0.0011*d
pBg-ZP3(214–348 aa) þ verapamil (10 lM) 49.6 6 1.6 P ¼ 0.0002*c, P ¼ 0.8382d
pBg-ZP3(214–348 aa) þ diltiazem (10 lM) 48.9 6 1.1 P ¼ 0.0001*c, P ¼ 0.6194d
pBg-ZP3(214–348 aa) þ nifedipine (10 lM) 35.6 6 1.6 P ¼ 0.0009*c, P ¼ 0.0032*d
a Capacitated sperm pretreated with or without respective inhibitor were incubated with pBg-ZP3(214–348 aa) at a concentration of 10 pmol/100 ll for 60
min.
b Percentage induction of acrosomal exocytosis was calculated by dividing the number of acrosome reacted sperm by total number of sperm counted and
multiplying by 100; values represent mean 6 SEM of at least three independent experiments.
c Statistical significance (P values) with respect to the medium control (calculated by one-way ANOVA followed by Newman-Keuls multiple comparisons
test).
d Statistical significance (P values) with respect to the pBg-ZP3(214–348 aa) (calculated by one-way ANOVA followed by Newman-Keuls multiple
comparisons test).
* Values are statistically significant.
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(Asn125 and Asn147) compared with one N-linked glycosylation
site in the C-terminal fragment (Asn272) [14]. The presence of
more than one band in the SDS-PAGE and Western blot profiles
for constructs expressed using the baculovirus expression
system may be due to differential glycosylation of the
polypeptide. Failure of expression of pAc-ZP3(1–175 aa) and
pAc-ZP3(1–370 aa) under the influence of native human ZP3
signal peptide (1–22 aa) in secreted form can be attributed to
failure of the host cell machinery to recognize foreign signal
peptide and inability to direct the polypeptide into the secretory
pathway. In contrast, pBg-ZP3(23–175 aa) expressed under the
influence of gp64 signal peptide (present in pBacGus-6 vector)
was secreted in culture supernatant of insect host cells. A similar
expression strategy was used to obtain ZP3 C-terminal
fragments in properly glycosylated and soluble form in culture
supernatant of the respective recombinant virus-infected host
insect cells.
The predominant glycosylation in the baculovirus-expressed
human ZP3 fragments was characterized by the binding of
lectins such as Con A and jacalin. Using immunocytochem-
istry, native human ZP has been shown to bind with both
lectins [13]. Purified baculovirus-expressed recombinant hu-
man ZP3 fragments after lectin-binding characterization were
assessed for their ability to induce acrosomal exocytosis in
capacitated human sperm. The acrosome reaction refers to the
sequential process of fusion and fenestration of the outer
acrosomal membrane and its overlying plasma membrane,
followed by release of the acrosomal contents that facilitate
penetration of the sperm through the ZP [22]. Baculovirus-
expressed human ZP3 C-terminal fragments pBg-ZP3(214–348 aa)
and pBg-ZP3(214–305 aa) in addition to pAc-ZP3(1–370 aa) were
able to induce the acrosome reaction in capacitated human
sperm, whereas human ZP3 N-terminal fragments expressed
with or without native signal peptide failed to do so.
Baculovirus-expressed human pAc-ZP2(1–745 aa) and fetuin
(used as negative controls) failed to significantly induce an
increase in the acrosome reaction in capacitated human sperm
compared with control medium (P . 0.05), suggesting the
importance of the ZP3 polypeptide backbone from its C-
terminal region. In murine models using papain or V8 protease-
digested ZP3, the mechanism to inhibit binding of sperm to the
egg and to induce acrosomal exocytosis in capacitated
spermatozoa was mapped to the C-terminus of ZP3 [23, 24].
Exon swapping and site-directed mutagenesis investigations
revealed that the sperm-combining site of ZP3 is located in its
carboxy terminal region encoded by exon 7 [25]. Mutation of
Ser332 and Ser334 resulted in complete inactivation of mouse
ZP3 as a sperm receptor [26]. Fusion constructs encoding
human IgG(Fc) and mouse ZP3 exon 7 or 8 were expressed in an
embryonal carcinoma cell line [27]. The recombinant human
IgG(Fc)/mouse ZP3(exon 7) bound specifically to plasma
membrane overlying the sperm head, whereas human IgG(Fc)/
mouse ZP3(exon 8) failed to do so [27]. Furthermore, using
recombinant overlapping ZP3 fragments, the inhibitory activity
for sperm-oocyte binding was mapped to a fragment encom-
passing exon 7 [28]. Collectively, these observations strongly
suggest that the mouse spermatozoa recognize and bind to a
region of mouse ZP3 polypeptide that is encoded by exon 7 and
is immediately downstream of its ZP domain. As already
mentioned, site-directed mutagenesis experiments revealed that
glycosylation of Ser332 and Ser334 may be critical in determining
the biological activity of mouse ZP3 [26]. In contrast to murine
model observations, LC-QTOF mass spectrometric analysis of
recombinant human ZP3 expressed in CHO-Lec3.2.8.1 cells
failed to demonstrate glycosylation of these Ser residues [14].
The observed reduced induction of the acrosome reaction
mediated by pBg-ZP3(214–305 aa) vs. by pBg-ZP3(214–348 aa) may
be due to the lack of these Ser residues and in addition the four
Cys residues (Cys319, Cys321, Cys322, and Cys327). The
glycosylation pattern observed in recombinant human ZP3
(expressed in CHO-Lec3.2.8.1 cells) may or may not correlate
with that of native human ZP3. Hence, the relevance of the
aforementioned Ser and Cys residues in imparting biological
activity of human ZP3 needs further elucidation. To assess the
importance of glycosylation in functional activity of ZP3 C-
terminal fragments, their E. coli-expressed counterparts were
used, and it was found that they were unable to induce the
acrosome reaction in capacitated human sperm in a statistically
significant manner. Moreover, chemical deglycosylation of
pBg-ZP3(214–348 aa) resulted in a significant decrease in the
acrosome reaction-inducing ability. The failure by E. coli-
expressed ZP3 C-terminal fragments to induce the acrosome
reaction may not be due to their nonbinding to capacitated
sperm, as the binding profile of ZP3(214–305 aa) revealed
characteristics similar to those observed with baculovirus-
expressed C-terminal fragments. These observations are in
agreement with recently published data from our laboratory
demonstrating that glycosylation of zona proteins per se is not
critical for binding to spermatozoa but is critical for induction of
acrosomal exocytosis [9]. However, the role of glycosylation
remains controversial in imparting biological activity to the
zona proteins [29].
At least two different receptor-mediated signaling pathways
in sperm plasma membrane have been shown to be responsible
for ZP-induced acrosomal exocytosis. One is a Gi protein-
coupled receptor that activates the phospholipase C (PLCB1)-
mediated signaling pathway, and the other is a tyrosine kinase
receptor coupled to PLCG [10, 30–32]. Both pathways
culminate in release of Ca2þ from the interior of the acrosome
to the cytosol. The increase in [Ca2þ]i and pH subsequently
leads to membrane fusion, resulting in acrosomal exocytosis.
As an inhibitor of the Gi protein-mediated signaling pathway,
PTX is known to inhibit human ZP-mediated acrosomal
exocytosis, whereas it fails to do so in human ZP4 [8, 10].
In the present study, the inhibition of pBg-ZP3(214–348 aa)-
mediated induction of acrosomal exocytosis by PTX suggests
that it is a specific event following a downstream signaling
pathway similar to that of full-length ZP3 polypeptide [8, 33,
34]. Requirement of extracellular Ca2þ to bring out pBg-
ZP3(214–348 aa)-mediated induction of the acrosome reaction
corroborates with earlier investigations using recombinant or
native ZP3 [10, 35]. The inhibition of pBg-ZP3(214–348 aa)-
mediated induction of the acrosome reaction by picrotoxin and
pimozide suggests the involvement of the Cl channel and the
T-type CCB, whereas failure of verapamil and diltiazem to
inhibit the same suggests that L-type Ca2þ channels may not
have an important role in downstream signaling events. These
inhibitors have been used to study the role of Ca2þ channels in
the acrosome reaction of human spermatozoa [36–38]. The
results corroborate with earlier reports in the literature [10].
In light of these observations, it can be hypothesized that the
C-terminal region of human ZP3 polypeptide, owing to a
unique disulfide linkage pattern that is different from that of
other human zona proteins, facilitates appropriate disposition
of critical glycosides, which are responsible for effecting
acrosomal exocytosis after coming in contact with capacitated
sperm. Acrosomal exocytosis of capacitated human sperm
mediated by pBg-ZP3(214–348 aa), is as effective as that induced
by ZP3(1–370 aa) and ZP3(1–424 aa) and is only slightly less than
that induced by calcium ionophore (P . 0.05). Dose-response
results with pBg-ZP3(214–348 aa) indicate that a dose as low as
600 ng/ml of recombinant protein is sufficient to significantly
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induce acrosomal exocytosis in capacitated human sperm. This
amount far exceeds the amount of ZP3 required for in vivo
induction of acrosomal exocytosis, in which the ZP surround-
ing a single human oocyte consists of ;5–8 ng of ZP3 [7, 39].
In contrast to recombinant human ZP3 (present in soluble
form), native ZP3 is associated with other zona proteins that
constitute the ZP matrix, and results of recent studies [8, 10] in
humans suggest that ZP4 and ZP3 induce acrosomal exocytosis
in human spermatozoa. In vivo, other zona proteins and various
physiological agents such as progesterone may act synergisti-
cally with ZP3 to effect acrosomal exocytosis.
In conclusion, the present study has delineated for the first
time (to our knowledge) a functionally active subdomain of
human ZP3 polypeptide that is competent to bind in the
acrosomal cap region of human spermatozoa and to induce
acrosomal exocytosis in the capacitated human sperm follow-
ing a downstream signaling pathway similar to that of full-
length human ZP3(1–424 aa). This finding suggests that the
functional activity of human ZP3 resides toward its C-terminus.
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